Annual Report Reveals 13% Sales Drop, 35% Net Income Decline for Fiscal 2025

summarizeSummary

United Guardian Inc. reported a 13% decrease in net sales and a 35% drop in net income for fiscal year 2025, primarily due to a sharp decline in cosmetic ingredient sales, despite growth in other segments.

check_boxKey Events

• Significant Revenue Decline

  Net sales decreased by 13% to $10.5 million in 2025 from $12.2 million in 2024.

• Sharp Drop in Net Income and EPS

  Net income fell by 35% to $2.1 million ($0.46 EPS) in 2025 from $3.25 million ($0.71 EPS) in 2024.

• Cosmetic Sales Plunge

  Sales of cosmetic ingredients decreased by 45%, largely due to a 54% drop in sales to the largest distributor, impacted by decreased demand and overstocking.

• New Distribution Agreement for Sexual Wellness Products

  In January 2026, the company entered a new distribution agreement with Brenntag Specialties for its Natrajel sexual wellness ingredients in North America and Lubrajel/Natrajel products in France.

auto_awesomeAnalysis

United Guardian Inc.'s annual report for fiscal year 2025 confirms a significant downturn in financial performance, with net sales decreasing by 13% and net income falling by 35%. This decline was primarily driven by a substantial 45% drop in cosmetic ingredient sales, particularly to its largest distributor, due to decreased demand in Asia and overstocking issues. While pharmaceutical sales saw a 15% increase and medical lubricants grew by 4%, these gains were insufficient to offset the broader decline. The company also disclosed a new distribution agreement for its sexual wellness products and a $300,000 settlement with a contract manufacturer, both expected to positively impact Q1 2026. However, the immediate financial results and a decrease in gross profit margin from 53% to 49% present a challenging picture for investors. The company's qualification as a 'specified small manufacturer' for Medicare Part D offers short-term rebate relief but anticipates significantly higher liabilities by 2031.